Psychedelics Portland VA opens psychedelic therapy clinic for mental health and substance use disorders Two clinical trials are under way at the Social Neuroscience & Psychotherapy Lab Rowan DunneApril 2, 2024
Psychedelics Billionaire Steve Cohen’s Point 72 hedge fund takes 8.1% stake in Cybin It now has 19 million shares of the psychedelic drug developer, the firm's first investment in a public entity of this variety Rowan DunneSeptember 19, 2023
Psychedelics Sage Institute receives grant to help continue its psychedelic therapy in California Cohen Foundation proudly supports organization dedicated to aiding underserved communities Rowan DunneJuly 27, 2022